Abstract

Although light skin types are associated with increased skin cancer risk, a lower incidence of both melanoma and nonmelanoma skin cancer (NMSC) has been reported in patients with vitiligo. We performed a systematic review and meta-analysis on the NMSC risk in patients with vitiligo, indicating a reduced relative risk ratio of NMSC in vitiligo. Furthermore, we propose a series of hypotheses on the underlying mechanisms, including both immune-mediated and nonimmune-mediated pathways. This study reveals insights into the relationship between vitiligo and keratinocyte cancer and can also be used to better inform patients with vitiligo.

Original languageEnglish
Pages (from-to)234-242
Number of pages9
JournalJournal of Investigative Dermatology
Volume144
Issue number2
Early online date2 Oct 2023
DOIs
Publication statusPublished - Feb 2024

Cite this